<SEC-DOCUMENT>0001213900-21-031045-index.html : 20210604 <SEC-HEADER>0001213900-21-031045.hdr.sgml : 20210604 <ACCEPTANCE-DATETIME>20210604171928 ACCESSION NUMBER: 0001213900-21-031045 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 9 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROONE MEDICAL TECHNOLOGIES Corp CENTRAL INDEX KEY: 0001500198 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 270863354 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-256830 FILM NUMBER: 21997437 BUSINESS ADDRESS: STREET 1: 7599 ANAGRAM DR CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: (952) 426-1383 MAIL ADDRESS: STREET 1: 7599 ANAGRAM DR CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: Original Source Entertainment, Inc. DATE OF NAME CHANGE: 20100830 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>ea141401-s3_neuroonemedical.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: ea141401-s3_neuroonemedical.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.7 <SEQUENCE>2 <FILENAME>ea141401ex4-7_neuroonel.htm <DESCRIPTION>FORM OF INDENTURE, BETWEEN THE REGISTRANT AND ONE OR MORE TRUSTEES TO BE NAMED <TEXT> Document 2 - file: ea141401ex4-7_neuroonel.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.9 <SEQUENCE>3 <FILENAME>ea141401ex4-9_neuroonel.htm <DESCRIPTION>FORM OF COMMON STOCK WARRANT AGREEMENT AND WARRANT CERTIFICATE <TEXT> Document 3 - file: ea141401ex4-9_neuroonel.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.10 <SEQUENCE>4 <FILENAME>ea141401ex4-10_neuroone.htm <DESCRIPTION>FORM OF PREFERRED STOCK WARRANT AGREEMENT AND WARRANT CERTIFICATE <TEXT> Document 4 - file: ea141401ex4-10_neuroone.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.11 <SEQUENCE>5 <FILENAME>ea141401ex4-11_neuroone.htm <DESCRIPTION>FORM OF DEBT SECURITIES WARRANT AGREEMENT AND WARRANT CERTIFICATE <TEXT> Document 5 - file: ea141401ex4-11_neuroone.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>6 <FILENAME>ea141401ex5-1_neuroone.htm <DESCRIPTION>OPINION OF HONIGMAN LLP <TEXT> Document 6 - file: ea141401ex5-1_neuroone.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>7 <FILENAME>ea141401ex23-1_neuroone.htm <DESCRIPTION>CONSENT OF BDO USA, LLP. <TEXT> Document 7 - file: ea141401ex23-1_neuroone.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ex5-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: ex5-1_001.jpg
</DOCUMENT> </SEC-DOCUMENT>